1. Home
  2. AGIO vs THR Comparison

AGIO vs THR Comparison

Compare AGIO & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.18

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Thermon Group Holdings Inc.

THR

Thermon Group Holdings Inc.

HOLD

Current Price

$41.18

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
THR
Founded
2007
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
AGIO
THR
Price
$27.18
$41.18
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$36.25
N/A
AVG Volume (30 Days)
1.5M
204.5K
Earning Date
02-12-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
36.04
EPS
N/A
1.75
Revenue
$44,791,000.00
$509,054,000.00
Revenue This Year
$27.83
$4.87
Revenue Next Year
$134.79
$4.78
P/E Ratio
N/A
$23.57
Revenue Growth
36.26
3.08
52 Week Low
$22.24
$23.05
52 Week High
$46.00
$41.92

Technical Indicators

Market Signals
Indicator
AGIO
THR
Relative Strength Index (RSI) 45.23 67.84
Support Level $27.30 $40.15
Resistance Level $28.87 $41.92
Average True Range (ATR) 1.00 1.07
MACD 0.30 0.18
Stochastic Oscillator 26.55 83.27

Price Performance

Historical Comparison
AGIO
THR

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.

Share on Social Networks: